Mumbai: Sun Pharmaceutical Industries Limited, based in India, has received final approval from the United States Food and Drug Administration (FDA) for the company’s application for Nicardipine Hydrochloride Injections (HCI), which is a short-term treatment for hypertension.

The United States-based pharmaceutical company Organon has launched its female contraceptive, called NuvaRing, in India.